Intrinsic Value

The intrinsic value of Polynovo Ltd (PNV) under the Base Case is 0.888 AUD per share. Compared with the current market price of 0.882 AUD, the stock appears Undervalued by 1% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

PNV Intrinsic Value
AU$0.888
Undervaluation 1%
Intrinsic Value
Price AU$0.882

PNV is cheaper than usual. This is its cheapest valuation in the past 5 years.

Monitor PNV
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$0.71
Get notified when the price drops into your buy zone
Intrinsic Value AU$0.89
Current Price AU$0.88
Margin of Safety 20% AU$0.71
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PNV

Fundamental Analysis

What Polynovo Does

Health Care

Polynovo makes medical devices for wound treatment and tissue repair. Its main product line uses a special synthetic material called Novosorb, which acts as a temporary scaffold for damaged skin and soft tissue while the body heals. The company focuses on products used in burns, complex wounds, and reconstructive surgery.

Headquarters
Australia AU
Employees
301
IPO date
Nov 26, 1998
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Polynovo Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PNV stock?

The intrinsic value for Polynovo Ltd (PNV) under the Base Case is 0.888 AUD.

Is PNV stock undervalued or overvalued?

Compared with the current market price of 0.882 AUD, the stock appears Undervalued by 1% .

Back to Top